Uncategorized

The American Board of Medical Specialties (ABMS) and its twenty-four Member Boards have launched a major initiative, "Continuing…

The Joint Commission recently released a report to help hospitals better understand and comply with new pain assessment and…

Novo Nordisk will pay roughly $58.7 million to resolve claims that the company’s sales force downplayed the importance of mandated…

The American Medical Informatics Association (AMIA) responded to a request for information (RFI) issued by the Office of the…

We have seen many large False Claims and Anti Kickback settlements with pharmaceutical companies and the prescriptions…

On January 12, 2017, the U.S. Department of Justice (DOJ) announced publicly that Zimmer Biomet Holdings, Inc. (Zimmer…

We have written for years about the transition in health care from volume-based to value-based payment models. But the process has…

Less than two weeks into his presidency, Donald Trump met with several leaders of pharmaceutical companies. During his campaign,…

Generic drug companies have been on the radar of the Department of Justice (“DOJ”) for several years, and recently the DOJ…

In September 2016, the United Nations Secretary General issued a report on its Panel on Access to Medicines. The Panel called for…